Microchimerism in Health and Disease
Journal:
Current Molecular Medicine
Volume:
2
Page:
525-535
Author(s):
Carol M. Artlett
Thiol-Dependent Cathepsins: Pathophysiological Implications and Recent Advances in Inhibitor Design
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1639-1658
Author(s):
Dieter Bromme and Jadwiga Kaleta
The Use of Cell Products for Treatment of Autoimmune Neuroinflammatory Diseases
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1497-1505
Author(s):
J. Ernerudh, G. Berlin and C. Ekerfelt
Novel Molecular Targets for Systemic Lupus Erythematosus
Journal:
Current Drug Targets
Volume:
3
Page:
223-228
Author(s):
Maria Marino, Maria Rossi, Menotti Ruvo and Giorgio Fassina
Alpha 4 Integrin Antagonists
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1229-1253
Author(s):
David Y. Jackson
Crystallization and Preliminary X-Ray Studies of the Fab Fragment from a Humanized Version of the Mouse Anti-Human Fas Antibody Hfe7a
Journal:
Protein & Peptide Letters
Volume:
9
Page:
259-263
Author(s):
Shuichiro Ito, Tomoko Takayama, Hiroyuki Hanzawa, Tohru Takahashi, Kenji Miyadai, Nobufusa Serizawa, Hideyuki Haruyama and Tadashi Hata
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Mucosal Immunity - Basic Principles, Ontogeny, Cystic Fibrosis and Mucosal Vaccination
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
83-95
Author(s):
Z. Vancikova
Oral Tolerance in the Treatment of Rheumatoid Arthritis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
45-52
Author(s):
Eric A. Toussirot
Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
219-227
Author(s):
Moorthy s.s. Palanki